Atea Pharmaceuticals
Atea Pharmaceuticals is a Healthcare & Life Sciences startup based in Boston, the United States, since gone public, 1 tracked investor.
About Atea Pharmaceuticals
Atea Pharmaceuticals is a company headquartered in Boston, the United States. Its most recent tracked round is IPO. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Atea Pharmaceuticals is a clinical-stage biopharmaceutical company developing oral direct-acting antiviral therapies, including treatments for hepatitis C virus and other serious viral diseases. The company has an exclusive ex-US partnership with Roche and is publicly traded on NASDAQ under the ticker AVIR.
Explore Atea Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.